Y-MABS THERAPEUTICS INC. - COMMON STOCK
6.0000
04-2月-25 16:45:00
15 分の遅延
株式
+0.2000
+3.45%
本日の幅
5.7500 - 6.0700
ISIN
N/A
ソース
NASDAQ
-
Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency
27 4 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Provides Regulatory Update on Omburtamab
20 4 2021 09:00:01 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces GPA33-SADA Data Presented at AACR
12 4 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces 2020 Financial Results and Recent Corporate Developments
25 2 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
22 2 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs to Announce 2020 Financial and Operating Results on February 25, 2021
19 2 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces Pricing of Public Offering of Common Stock
17 2 2021 19:14:43 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces Proposed Public Offering of Common Stock
16 2 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics to Present At 39th Annual J.P. Morgan Healthcare Conference
06 1 2021 09:00:00 提供 Nasdaq GlobeNewswire